Related Experiment Videos
Peritoneal fluid markers of mesothelial cells and function
1Department of Nephrology, Academic Medical Center, Amsterdam, The Netherlands.
Advances in Renal Replacement Therapy
|August 1, 1998
Summary
Early detection of peritoneal membrane changes in dialysis patients is possible using biomarkers in peritoneal fluid. These markers, including cancer antigen 125, offer accessible insights into membrane health and require further study.
Area of Science:
- Nephrology
- Biomarker Discovery
- Peritoneal Dialysis
Background:
- Peritoneal structural changes can lead to functional decline of the peritoneal membrane.
- Early detection of these changes is crucial for managing peritoneal dialysis (PD) patients.
Purpose of the Study:
- To review current knowledge on mesothelial cell markers in peritoneal effluent for early detection of peritoneal membrane changes.
- To assess the validity of using peritoneal fluid biomarkers for monitoring PD patients.
Main Methods:
- Literature review summarizing existing studies on peritoneal biomarkers.
- Analysis of markers such as cancer antigen (CA) 125, phospholipids, hyaluronan, and coagulation factors.
Main Results:
- Several markers in peritoneal effluent show potential for assessing peritoneal membrane status.
- Limited studies indicate this approach is promising for individual PD patient monitoring.
Conclusions:
- Biomarkers in peritoneal effluent offer a viable method for early detection of peritoneal structural and functional changes.
- Further research, particularly combining biomarker analysis with functional studies and biopsies, is warranted.